AZN vs GNPX · P/E 28, $288.38B cap vs $5.3M cap
AstraZeneca PLC (AZN) versus Genprex Inc (GNPX) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Genprex Inc (GNPX) is a biotechnology company listed on NASDAQ.
AZN does not have a complete income-statement cache yet.
GNPX does not have a complete income-statement cache yet.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. GNPX currently screens at market cap $5.3M.
Not investment advice. Open the AZN and GNPX stock pages for the full models.
Not investment advice.